Blue Fin Capital, Inc. Amgen Inc Transaction History

Blue Fin Capital, Inc.

$517 Million
Q3 2024

A detailed history of Blue Fin Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 4,711 shares of AMGN stock, worth $1.24 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

4,711

Previous 4,824 2.34%

Holding current value

$1.24 Million

Previous $1.51 Million 0.66%

% of portfolio

0.29%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $34,959 - $38,123	-113 Reduced 2.34%	4,711 $1.52 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $14,714 - $17,881	56 Added 1.17%	4,824 $1.51 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $47,589 - $57,447	-177 Reduced 3.58%	4,768 $1.36 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $26,848 - $30,288	-105 Reduced 2.08%	4,945 $1.42 Million
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $27,549 - $34,203	-126 Reduced 2.43%	5,050 $1.36 Million
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $16,713 - $19,762	-78 Reduced 1.48%	5,176 $1.15 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $77,445 - $94,393	-343 Reduced 6.13%	5,254 $1.27 Million
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $71,915 - $91,377	-314 Reduced 5.31%	5,597 $0
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $96,068 - $108,348	428 Added 7.81%	5,911 $1.33 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $13,842 - $15,404	-60 Reduced 1.08%	5,483 $1.33 Million
Q1 2022 Apr 12, 2022	BUY	$219.27 - $242.57 $7,893 - $8,732	36 Added 0.65%	5,543 $1.34 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $5,767 - $6,600	29 Added 0.53%	5,507 $1.24 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $18,255 - $21,388	-86 Reduced 1.55%	5,478 $1.16 Million
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $51,387 - $57,010	-220 Reduced 3.8%	5,564 $1.36 Million
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $82,994 - $96,716	-374 Reduced 6.07%	5,784 $1.44 Million
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $8,222 - $9,791	-38 Reduced 0.61%	6,158 $1.42 Million
Q3 2020 Oct 28, 2020	BUY	$234.65 - $260.95 $15,721 - $17,483	67 Added 1.09%	6,196 $1.57 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $107,410 - $131,807	-543 Reduced 8.14%	6,129 $1.45 Million
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $46,471 - $61,633	-255 Reduced 3.68%	6,672 $1.35 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $23,840 - $30,643	-126 Reduced 1.79%	6,927 $1.67 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $97,327 - $116,618	-559 Reduced 7.34%	7,053 $1.36 Million
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $6,001 - $7,034	36 Added 0.48%	7,612 $1.4 Million
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $8,320 - $9,378	46 Added 0.61%	7,576 $1.44 Million
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $14,450 - $16,868	81 Added 1.09%	7,530 $1.47 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $125,441 - $141,418	677 Added 10.0%	7,449 $1.54 Million
Q2 2018 Aug 06, 2018	BUY	$166.05 - $186.51 $15,940 - $17,904	96 Added 1.44%	6,772 $1.25 Million
Q4 2017 Jan 26, 2018	BUY	$168.79 - $188.59 $62,452 - $69,778	370 Added 5.87%	6,676 $1.16 Million
Q3 2017 Oct 11, 2017	BUY	$167.29 - $191.0 $1.05 Million - $1.2 Million	6,306	6,306 $1.18 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Fin Capital, Inc. with notifications on news.

Account

Blue Fin Capital, Inc. Amgen Inc Transaction History